Lawsuit over weight loss drug and optic neuropathy
Weight loss and diabetes treatment drug manufacturers are facing lawsuits from hundreds of patients due to a possible link between their medications and a rare condition called "non-arteritic ischemic optic neuropathy," which causes permanent vision loss and resembles a stroke in the eye. The companies deny the rumors and affirm that current scientific evidence does not establish a consistent relationship between the drugs and this condition, while the U.S. Food and Drug Administration and the European Medicines Agency continue investigating the potential connection without issuing any official warnings so far. Doctors advise patients not to stop taking the medications without medical consultation, emphasizing that their health benefits often outweigh the potential risks.
Notice: This Is an AI-Generated Summary
Comments (0)